Update
$Actinium(ATNM.US$ Reuters· 2 mins ago
Actinium Pharmaceuticals Inc- Iomab-B Achieved Primary Endpoint of Durable Complete Remission (Dcr) With High Statistical Significance (P<0.0001)
Actinium Pharmaceuticals Inc- Iomab-B Achieved Primary Endpoint of Durable Complete Remission (Dcr) With High Statistical Significance (P<0.0001)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
